PetVivo Holdings Inc (OTCQB: PETV) Stock In Focus After The Latest News

On November 26 PetVivo Holdings Inc (OTCQB: PETV) was one of the more innovative companies to have come into focus following a significant announcement, and this morning it could be in focus among investors. Hence, it could be a good time to actually look into the announcement a bit more closely.

New Exhibit

The company announced that it would be involved in an exhibition at the AAEP (American Association of Equine Practitioners) event that would be held from December 8 to December 10. It would be held at the Orange County Convention Center, Exhibit Halls B, C and D in Orlando, Florida.

At the above mentioned event PetVivo Holdings would exhibit its flagship product Spryng, equipped with OsteoCushion Technology. The product in question was described as an injectable intra-articular veterinary medical device made up of matrix microparticles.

Further Information

The company went on to state that the microparticles in the product had been discovered to have the capability of absorbing into the joint synovial lining in animals and then getting integrated with the subsynovial tissue. PetVivo Holdings went on the note that everyone at the company was excited at the prospect of exhibiting the product at the event. It remains to be seen if the stock gets any traction today or not.

Key Quote

“We are incredibly excited to participate again this year at the AAEP Convention. The AAEP provides us an excellent opportunity to demonstrate to leading equine veterinarians our innovative medical device for the management of osteoarthritis, Spryng with OsteoCushion Technology,” said PetVivo CEO, John Lai. “We welcome the opportunity to support AAEP and participate in this convention to explain the advantages of Spryng including the beneficial results we have witnessed when administered to horses and companion animals throughout the U.S.”

Technicals

+/- EMA(20)0.51 (-1.96%)
+/- SMA(50)0.52 (-3.85%)
+/- SMA(200)0.68 (-26.47%)
5-Day Perf.+6.16%
1-Month Perf.-0.2%
3-Month Perf.-9.09%
6-Month Perf.-18.03%
YTD Perf.-52.83%
1-Year Perf.-19.35%
RSI(14)46.64
ATR(14)0.06
ADX(14)29.87
Beta (5Y)1.63

Ian Leigh

Ian Leigh is a specialist in analyzing stocks, SEC and OTC filings, and financials of public and privately-held companies. He has played a significant role in M&A activity, consulting with publicly-held firms on acquisitions and divestitures. He also consults on valuations and branding. He lectures at major universities and teaches at specialty financial schools.